Court
The ruling means Teva’s flagship multiple sclerosis treatment’s patent remains valid until September 2015. The US Supreme Court has ruled in favor of...
Hi, what are you looking for?
The ruling means Teva’s flagship multiple sclerosis treatment’s patent remains valid until September 2015. The US Supreme Court has ruled in favor of...
The Israel Patent Office has granted Israel’s Oramed Pharmaceuticals, a developer of oral drug delivery systems, a patent for its invention, titled “Methods and...
Uber wants to patent its surge-pricing feature. It is one of 13 items that the company has filed with the U.S. Patent Office and...
The European Patent Office has signed a Patent Prosecution Highway (PPH) pilot program with the Israel Patent Office which will enable the accelerated treatment...
– Leading Israeli Pharmaceutical company Teva has mixed results in its initial U.S. Supreme Court hearing over the possible loss of patent protection for...
Israel’s Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer and inflammatory diseases, has received a...
Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) today announced that a positive judgment has been given by the UK High Court in support of Teva’s case...
– A 2011 study has shown that Patent Trolls (or Non Practicing Entity (NPE)) cost tech companies $29. – Late last Friday, Texas based...
– The ruling has major implications for Israelis moving abroad write Advs. Noa Lev Goldstein and Adam Kadesh. – – / Noa Lev Goldstein...
– – Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) has reached settlements with Sandoz, Actavis, Lupin and Apotex with respect to U.S. Patent 7, 132, 570...